攜程夥螞蟻等發出入境遊倡議 目標明年服務入境遊人數比2019年增1.5倍
2023中國國際旅遊交易會在昆明開幕。攜程推出系列「組合拳」,助推入境游發展。其中包括:與中國對外文化交流協會簽署戰略合作備忘錄(MOU);宣布搭建入境游服務平台;聯合螞蟻集團、中旅旅行、遠海國際、桂林唐朝國旅等企業發出入境游協作聯盟倡議。
倡議中指,將分別從入境游服務門戶、境外卡移動支付、內地目的地海外傳播及團隊游服務品質等維度入手,推動入境游全鏈路便利化,提高外國遊客遊玩體驗。
攜程表示,將在攜程國際版Trip上搭建入境游服務平台。隨著國際航班的逐步恢復,加之各項積極舉措,攜程力爭2024年服務的入境遊人數比2019年增長超過150%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.